LLY Aug 2024 1060.000 call
- Yahoo Finance
FDA panel votes unanimously for Eli Lilly's Alzheimer's treatment
An FDA panel voted unanimously to support Eli Lilly's Alzheimer's drug for use in adults 60-85 years old.
- Yahoo Finance
Eli Lilly exec on weight-loss drugs: 'It's not just a flash in the pan'
Eli Lilly may be riding high on its diabetes and weight-loss treatments Mounjaro and Zepbound — which Wall Street estimates could net the company $13.5 billion in 2024 — but the success comes with ongoing criticism about pricing and access.
- Associated Press Finance
Alzheimer's drug that can slow disease gets backing from FDA advisers
A closely watched Alzheimer's drug from Eli Lilly won the backing of federal health advisers on Monday, setting the stage for the treatment's expected approval for people with mild dementia caused by the brain-robbing disease. A panel of Food and Drug Administration advisers voted unanimously that the drug's ability to modestly slow the disease outweighs its risks, including side effects like brain swelling and bleeding that will have to be monitored. The FDA will make the final decision on approval later this year.
